Skip to main content
. 2024 Nov 15;6(4):104–113. doi: 10.46989/001c.124593

Table 1. Demographics.

N Missing N = 109
JACIE accredited 0
No 11 (10%)
Yes 78 (72%)
In process/Pending 15 (14%)
Don’t know 5 (4.6%)
Academic centre 0 95 (87%)
Type of patients 0
Children (0-18 years) 30 (28%)
Adults (>18 years) 66 (61%)
Both 13 (12%)
Practice area: Day Hospital 0 28 (26%)
Practice area: Bone Marrow Transplant In-Patient Unit 0 90 (83%)
Practice area: Bone Marrow Transplant Out-Patient Unit 0 58 (53%)
Practice area: Other 0 28 (26%)
Role 0
Registered Nurse 26 (24%)
Research Nurse 9 (8.3%)
Ward Manager 12 (11%)
Specialist Nurse 59 (54%)
Quality Manager 3 (2.8%)
Years experience in Haematology/BMT 0
0 - 2 years 4 (3.7%)
2 - 5 years 7 (6.4%)
5 - 10 years 24 (22%)
10 - 15 years 26 (24%)
> 15 years 48 (44%)
Experience delivering unlicensed advanced therapies (ATMPs) 4
None 32 (30%)
Some 43 (41%)
Experienced 23 (22%)
Don’t know 7 (6.7%)
Experience delivering licensed advanced therapies (ATMPs) 2
None 23 (21%)
Some 37 (35%)
Experienced 41 (38%)
Don’t know 6 (5.6%)
Delivery of ATMP at your centre 0
No 21 (19%)
Yes 75 (69%)
Not yet, but in the near future 13 (12%)
Follow-up of patients at other centre 0
No 63 (58%)
Yes 35 (32%)
Not yet, but in the near future 11 (10%)

ATMPs – Advanced Therapy Medicinal Products; BMT – Bone Marrow Transplant; JACIE - Joint Accreditation Committee of the International Society for Cell and Gene Therapy and the European Group for Blood and Marrow Transplantation